Cancer Research Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–5 of 5 articles
Earlier
High impact AnalysisJun 6, 2026
Celcuity Expands VIKTORIA-2 Trial as Shares Trade Below Analyst Targets
breast cancer · 4 min
Dr. Sarah MitchellHigh impact AnalysisJun 2, 2026
ASCO 2026 Preview: Key Data and Trends in Cancer Research
pancreatic cancer · 7 min
Dr. Sarah MitchellHigh impact AnalysisJun 2, 2026
Experimental pancreatic cancer drug offers new hope in major trial
pancreatic cancer · 7 min
Dr. Sarah MitchellHigh impact AnalysisJun 2, 2026
FDA grants orphan status to oxaliplatin for hard-to-treat pancreatic cancer
FDA · pancreatic cancer · 9 min
Dr. Sarah MitchellMedium impact AnalysisMay 29, 2026
STAT+: ASCO Preview: Key Insights for Pharma Leaders
2 min
Dr. Sarah MitchellExplore intelligence